Check the time stamp on this data. Updated AI-Generated Signals for Siga Technologies Inc. (SIGA) available here: SIGA. Type ...

The most recent trading session ended with Siga Technologies Inc. (SIGA) standing at $6.23, reflecting a -0.24% shift from the previouse trading day's closing. This move lagged the S&P 500's daily ...

Siga Technologies Inc. (SIGA) closed the most recent trading day at $6.35, moving +0.32% from the previous trading session. This move lagged the S&P 500's daily gain of 1.83%. Elsewhere, the Dow saw ...

(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox ...

Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as well as complications following smallpox ...

Taking place at Farnborough International Exhibition Centre on 4th – 6th February 2025, it is the UK’s largest annual ...

In partnership with Japan Biotechno Pharma, SIGA’s exclusive distributor in Japan, SIGA has delivered an order of TEPOXX to help build Japan’s strategic national stockpile. “The approval of TEPOXX in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox ...